Utah Medical Products
UTMD
79 hedge funds and large institutions have $149M invested in Utah Medical Products in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 32 increasing their positions, 23 reducing their positions, and 4 closing their positions.
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
39% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 23
4% more funds holding
Funds holding: 76 → 79 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less capital invested
Capital invested by funds: $159M → $149M (-$9.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EA
Emerald Acquisition
Seattle,
Washington
|
+$637K |
| 2 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$519K |
| 3 |
BPM
Bowling Portfolio Management
Cincinnati,
Ohio
|
+$491K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$416K |
| 5 |
JP Morgan Chase
New York
|
+$379K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
-$1.82M |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.05M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$650K |
| 4 |
MDCM
Morgan Dempsey Capital Management
Menomonee Falls,
Wisconsin
|
-$604K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$493K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
76
Tower Research Capital (TRC)
New York
| $7K | -$24.1K | -379 | -76% |
|
|
DA
77
Denali Advisors
San Diego,
California
| $2K | – | – | – |
|
|
TCIM
78
TIAA CREF Investment Management
New York
| $651 | – | – | – |
|
|
TC
79
TFS Capital
West Chester,
Pennsylvania
| – | -$1.05M | -16,643 | Closed |
|
|
NI
80
Numeric Investors
Boston,
Massachusetts
| – | -$259K | -4,105 | Closed |
|
|
GCP
81
GSA Capital Partners
London,
United Kingdom
| – | -$258K | -4,100 | Closed |
|
82
Two Sigma Advisers
New York
| – | -$202K | -3,200 | Closed |
|
|
PAM
83
Panagora Asset Management
Boston,
Massachusetts
| – | +$445 | +7 | New |
|
UTMD Hedge Fund Activity: Q3 2016 in Review
79 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q3 2016, worth a combined $149M — down 6.2% from $159M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new UTMD positions and 4 closed out — a net gain of 3 holders — while 32 added to existing stakes and 23 trimmed.
The largest buyer was Emerald Acquisition, adding an estimated $637K. The largest seller was Nine Ten Capital Management, cutting an estimated $1.82M.
- 79 institutional investors held Utah Medical Products (UTMD) as of Q3 2016, up from 76 in Q2 2016.
- Funds reported $149M of Utah Medical Products stock for Q3 2016, down 6.2% quarter-over-quarter.
- 7 funds opened new Utah Medical Products positions in Q3 2016 and 4 closed out, a net change of +3 holders.
- The largest Utah Medical Products buyer in Q3 2016 was Emerald Acquisition, an estimated $637K added.
- The largest Utah Medical Products seller in Q3 2016 was Nine Ten Capital Management, an estimated $1.82M sold.
Based on aggregated 13F filings for Q3 2016.